- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Progression of Non-small Cell Lung Cancer in Italy
Total 736 results
-
Istituto Nazionale per lo Studio e la Cura dei...Unknown
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Regione LombardiaCompletedNon-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IVItaly
-
Eli Lilly and CompanyWithdrawnMetastatic Squamous Non-Small Cell Lung Cancer | Locally Advanced Squamous Non-Small Cell Lung CancerItaly, Romania, Germany, Belgium, Russian Federation, United States, United Kingdom
-
Fondazione Ricerca TraslazionaleNot yet recruitingNon-small-cell Lung Cancer PatientsItaly
-
National Cancer Institute, NaplesActive, not recruitingNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIBItaly
-
University of Milano BicoccaAzienda Ospedaliera San Gerardo di MonzaRecruitingNon-small Cell Lung CancerItaly
-
Campus Bio-Medico UniversityUnknownNon-Small Cell Lung CancerItaly
-
National Cancer Institute, NaplesActive, not recruitingNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIBItaly
-
Clovis Oncology, Inc.TerminatedSmall Cell Lung Cancer | Non-Small Cell Lung Cancer | NSCLC | Lung Cancer | Metastatic Lung Cancer | SCLC | Stage IV Lung Cancer | Advanced Lung Cancer | Squamous Non-Small Cell Lung CancerUnited States, Italy, Germany, France, Spain
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerSpain, Italy, Germany, France
-
SanofiCompletedNon-small Cell Lung Cancer Stage IVSpain, France, Germany, Italy, United Kingdom
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerMexico, Italy, Australia, Spain
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CancerSpain, Netherlands, Austria, Greece, Germany, Italy
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung CancerTaiwan, Spain, Italy, United States, Korea, Republic of, France
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerUnited States, Taiwan, Italy, Korea, Republic of
-
Istituto Scientifico Romagnolo per lo Studio e...CompletedNon-small Cell Lung Cancer MetastaticItaly
-
SciClone PharmaceuticalsUnknown
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerSpain, Singapore, Germany, Switzerland, Australia, France, Italy, United States
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerItaly
-
Southern Italy Cooperative Oncology GroupCompletedNon-Small Cell Lung Cancer | Stage IIIB or IVItaly
-
Gruppo Oncologico Italiano di Ricerca ClinicaUnknownAdvanced Non-Small Cell Lung CancerItaly
-
Eisai Inc.Quintiles, Inc.CompletedNon Small Cell Lung CancerUkraine, Germany, United States, Italy, Czechia
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHong Kong, Spain, Russian Federation, France, Bulgaria, Germany, Estonia, Italy, Poland, Taiwan, United Kingdom, Singapore, Ireland, Belgium
-
Bristol-Myers SquibbTerminatedNon-small Cell Lung CancerSpain, United States, Belgium, France, Italy, Netherlands, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
Peregrine PharmaceuticalsCompletedCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Non-Small-Cell Lung Carcinoma | Non-Small-Cell Lung Cancer Stage IIIB | Non-Small-Cell Lung Cancer Stage IV | Non-Small-Cell Lung Cancer MetastaticUnited States, Australia, Belgium, France, Germany, Greece, Hungary, Italy, Korea, Republic of, Romania, Russian Federation, Spain, Taiwan, Ukraine
-
Fondazione Ricerca TraslazionaleRecruitingMetastatic Non Small Cell Lung CancerFrance, Spain, Italy
-
Istituto Scientifico H. San RaffaeleUnknown
-
Gruppo Oncologico Italiano di Ricerca ClinicaBioikos Ambiente Srl; Istituto Toscano Tumori; Temas srl; Mipharm S.p.A.; Bristol...Active, not recruitingSquamous Non-small Cell Lung CancerItaly
-
Novartis PharmaceuticalsTerminatedSquamous Non-small Cell Lung CancerGermany, Spain, Korea, Republic of, Belgium, Italy, United States, France, Sweden
-
ETOP IBCSG Partners FoundationAstraZenecaRecruitingImmunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC (CHESS)Non-small Cell Lung Cancer | Oligometastasis | Stage IVSwitzerland, Netherlands, Spain, Italy
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerItaly
-
National Cancer Institute, NaplesTerminatedAdvanced Non-Small Cell Lung CancerItaly
-
National Cancer Institute, NaplesActive, not recruitingNon-squamous Non-small Cell Lung CancerItaly
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung CancerSpain, Italy, Poland, Brazil, Turkey, Serbia, France, Korea, Republic of, Romania, Hungary, Russian Federation, United States, United Kingdom, Germany, Greece, Japan, Thailand, Ukraine, China
-
Zhejiang Genfleet Therapeutics Co., Ltd.RecruitingAdvance Non-small Cell Lung CancerSpain, Italy, Greece
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerUnited States, France, Italy, Korea, Republic of, Germany, Portugal
-
Genzyme, a Sanofi CompanyCompletedNon Small Cell Lung CancerItaly
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerCanada, Spain, Australia, Singapore, Germany, Italy, Korea, Republic of, Norway, Taiwan, United States, France
-
SanofiActive, not recruitingNon-squamous Non-small Cell Lung CancerBelgium, Italy, Spain, Japan, United States, France, Turkey
-
National Cancer Institute, NaplesCompletedAdvanced Non-Small Cell Lung CancerItaly
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerBelgium, Spain, United Kingdom, Germany, Italy, Poland, France
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerUnited States, France, Germany, Korea, Republic of, Taiwan, United Kingdom, Spain, Italy, Japan, Australia
-
Bristol-Myers SquibbActive, not recruitingNon-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerAustralia, Russian Federation, United States, Argentina, Austria, Belgium, Brazil, Chile, France, Germany, Italy, Mexico, Poland, Romania, Spain, Switzerland, United Kingdom, Ireland, Netherlands
-
Bristol-Myers SquibbCompletedSquamous Cell Non-small Cell Lung CancerUnited States, Italy, France, Germany
-
AstraZenecaCompletedNon-small Cell Lung Cancer (NSCLC)United Kingdom, United States, Italy, Spain, France, Germany
-
ETOP IBCSG Partners FoundationJanssen PharmaceuticalsRecruitingNon Small Cell Lung CancerSpain, France, Switzerland, United Kingdom, Singapore, Italy, Netherlands
-
iTeos Belgium SARecruitingMetastatic NSCLC - Non-Small Cell Lung Cancer | Locally Advanced NSCLC - Non-Small Cell Lung CancerUnited Kingdom, Spain, Belgium, France, United States, Switzerland, Italy, Germany, Canada, Czechia, Poland
-
Fondazione Ricerca TraslazionaleUnknownNon Small Cell Lung Cancer | Metastatic Cancer | Advanced CancerItaly
-
BeiGeneRecruitingNon-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Spain, France, Malaysia, Italy, Canada, Thailand, Georgia, Brazil, Korea, Republic of, Singapore, Moldova, Republic of, Romania